Skip to main content
Fig. 7 | World Journal of Surgical Oncology

Fig. 7

From: Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer

Fig. 7

a Forest plots of the pooled RR for the sub-analysis of cycle number effect in DFS in epirubicin arms between sequential and concurrent regimens. The results indicated that fewer cycles (4 cycles) of concurrent treatment had worse DFS (RR, 1.16; 95% CI, 1.06-1.27, P = 0.0009). b Forest plots of the pooled RR for the sub-analysis of cycle number effect in DFS in epirubicin arms between sequential and concurrent regimens. The results indicated that fewer cycles (4 cycles) of concurrent treatment had worse OS (RR, 1.18; 95% CI, 1.05-1.33, P = 0.007)

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us